Biology subjects

Kuipers, J.

Publications and source records attributed to Kuipers, J..

At least 19 recordsLinked to original sources

bioRxiv2026

Reliable single-cell perturbations explain and improve model performance

Predicting single-cell transcriptional responses to perturbations is central to building the virtual cell, yet recent benchmarks show that simple baseline methods often outperform complex models, and model comparisons depend on the evaluation metric. Most studies assume that preprocessed RNA sequencing data are reliable ground truth for both training and evaluation. Here, we test this assumption by measuring the reliability of perturbations and their alignment with shared perturbation responses, classifying each perturbation as specific, shared, or unreliable. Among 7,170 perturbations from 29 datasets, 65% are unreliable, 11% shared, and 24% specific. Applying these quality labels to published benchmarks shows that model comparisons depend on perturbation quality. Training with reliable perturbations alone matches or outperforms full-data performance while using 55% of all training perturbations. Our framework also enables prospective experimental design: for most perturbations, a 28-cell pilot experiment accurately predicts how many cells a full screen needs to be reliable.

bioinformatics↗

bioRxiv2026

Clone-level multi-modal prediction of tumour drug response

Tumour heterogeneity presents a major challenge for precision oncology, as genetically and phenotypically distinct tumour clones may respond differently to therapy. To address this, we introduce scClone2DR, a probabilistic multi-modal framework that predicts drug responses at the level of individual tumour clones by integrating single-cell DNA and RNA sequencing with ex-vivo drug-screening data. In simulations, scClone2DR substantially outperforms alternatives in recovering true drug-effects and clonal sensitivities. Applied to 60 melanoma and 21 acute myeloid leukaemia patient samples, the method identifies heterogeneous clonal responses, yields biologically meaningful feature rankings, highlights clones that may be resistant to treatment, and improves the prediction of clinical outcomes compared to models ignoring clonal structure. These results demonstrate that modelling tumour evolution and clonal diversity is crucial for accurate drug-response prediction and provides a foundation for more effective, clone-aware precision oncology.

cancer biology↗

bioRxiv2025

Phylogenetic tree inference from single-cell RNA sequencing data

Single-cell RNA sequencing technologies enable the large-scale measurement of gene expression profiles at the individual cell level to assess cellular diversity and function. In oncology, leveraging these single-cell transcriptomic data to reconstruct the phylogenetic relationships among cancer cells can provide insights into tumor evolution, metastasis formation, and the development of treatment resistance. However, phylogenetic inference from single-cell RNA sequencing is challenging due to sparse and noisy data and large dataset sizes. We present a novel tree inference method designed for such data that takes reference and alternative read counts of single-nucleotide variants and reconstructs a phylogenetic tree of the sequenced cells via maximum likelihood using a random-scan greedy search. To overcome local optima in the search, our algorithm alternates between two different tree representations: cell lineage trees, where cells are represented by nodes and mutations are attached to edges, and mutation trees, where mutation nodes encode the mutational events and cells are attached to them. Because a local optimum in one tree space generally does not correspond to a local optimum in the other space, we maximize the likelihood by switching between the two tree spaces until convergence is achieved in both. We demonstrate superior performance of our approach on simulated data with complex clonal architectures compared to existing methods. Furthermore, we show its applicability to cancer single-cell RNA sequencing data, which allows us to link evolutionary trajectories of cells to their gene expression profiles.

genomics↗

bioRxiv2025

Cell lineage inference from mitochondrial mutations

Tracing genealogical relationships between cells and their molecular states is essential for understanding tissue development, maintenance and disease. We present mt-SCITE, a computational method that reconstructs cell division histories from mitochondrial mutations in single cells. On simulated and experimental benchmarks, mt-SCITE outperformed existing methods in terms of cell lineage reconstruction, and scaled to thousands of cells. Applied to expanded CD8+ T cells following vaccination, mt-SCITE resolved subclonal relationships and revealed clones with predominantly memory-like, effector-like, or mixed states. mt-SCITE robustly identifies clonally related populations and resolves substructure within them, providing a broadly applicable approach to study cell lineage development.

bioinformatics↗

bioRxiv2025

Bayesian inference of fitness landscapes via tree-structured branching processes

MotivationThe complex dynamics of cancer evolution, driven by mutation and selection, underlies the molecular heterogeneity observed in tumors. The evolutionary histories of tumors of different patients can be encoded as mutation trees and reconstructed in high resolution from single-cell sequencing data, offering crucial insights for studying fitness effects of and epistasis among mutations. Existing models, however, either fail to separate mutation and selection or neglect the evolutionary histories encoded by the tumor phylogenetic trees. ResultsWe introduce FiTree, a tree-structured multi-type branching process model with epistatic fitness parameterization and a Bayesian inference scheme to learn fitness landscapes from single-cell tumor mutation trees. Through simulations, we demonstrate that FiTree outperforms state-of-the-art methods in inferring the fitness landscape underlying tumor evolution. Applying FiTree to a single-cell acute myeloid leukemia dataset, we identify epistatic fitness effects consistent with known biological findings and quantify uncertainty in predicting future mutational events. The new model unifies probabilistic graphical models of cancer progression with population genetics, offering a principled framework for understanding tumor evolution and informing therapeutic strategies. Availability and implementationThe Python package FiTree and the analysis workflows are available at https://github.com/cbg-ethz/FiTree.

bioinformatics↗

bioRxiv2024

DemoTape: Computational demultiplexing of targeted single-cell sequencing data

BackgroundSingle-cell sequencing can provide novel insights into the understanding and treatment of diseases. In cancer, for example, intratumor heterogeneity is a major cause of treatment resistance and relapse. Although technological progress has substantially increased the throughput of sequenced cells, single-cell sequencing remains cost and labor-intensive. Multiplexing, i.e., the pooling and subsequent joint preparation and sequencing of samples, followed by a demultiplexing step, is a common practice to reduce expenses and confounding batch effects, especially in single-cell RNA sequencing. ResultsHere, we introduce demoTape, a computational demultiplexing method for targeted single-cell DNA sequencing (scDNA-seq) data based on a distance metric between individual cells at single-nucleotide polymorphisms loci. To validate demoTape, we sequence three B-cell lymphoma patients separately and multiplexed on the Tapestri platform. We find similar genotypes, clones, and evolutionary histories in all three samples when comparing the individual with the demultiplexed samples. Using the three individually sequenced samples, we simulate multiplexed ground truth data and show that demoTape outperforms state-of-the-art demultiplexing methods designed for RNA sequencing data. Additionally, we demonstrate through downsampling that the inferred clonal composition remained largely stable for samples with fewer cells despite the inevitable loss in resolution of low-frequency clones. ConclusionsMultiplexing and subsequent genotype-based demultiplexing of scDNA-seq will reduce costs and workload, eventually allowing the sequencing of more samples. This will open new possibilities and accelerate the investigation of biological questions where cellular heterogeneity on the genomic level plays a crucial role.

bioinformatics↗

bioRxiv2023

Network-based clustering unveils interconnected landscapes of genomic and clinical features across myeloid malignancies

Myeloid malignancies exhibit considerable heterogeneity with overlapping clinical and genetic features among different subtypes. Current classification schemes, predominantly based on clinical features, fall short of capturing the complex genomic landscapes of these malignancies. Here, we present a data-driven approach that integrates mutational features and clinical covariates within networks of their probabilistic relationships, enabling the discovery of de novo cancer subgroups. In a cohort of 1323 patients across acute myeloid leukemia, myelodysplastic syndromes, chronic myelomonocytic leukemia and myeloproliferative neoplasms, we identified novel subgroups that outperform established risk classifications in prognostic accuracy. Our findings suggest that mutational patterns are often shared across different types of myeloid malignancies, with distinct subtypes potentially representing evolutionary stages en route to leukemia. Within the novel subgroups, our integrative method discerns unique patterns combining genomic and clinical features to provide a comprehensive view of the multifaceted genomic and clinical landscape of myeloid malignancies. This in turn may guide the development of targeted therapeutic strategies and offers a pathway to enhanced patient stratification.

cancer biology↗

bioRxiv2023

DelSIEVE: joint inference of single-nucleotide variants, somatic deletions, and cell phylogeny from single-cell DNA sequencing data

With rapid advancements in single-cell DNA sequencing (scDNA-seq), various computational methods have been developed to study evolution and call variants on single-cell level. However, modeling deletions remains challenging because they affect total coverage in ways that are difficult to distinguish from technical artifacts. We present DelSIEVE, a statistical method that infers cell phylogeny and single-nucleotide variants, accounting for deletions, from scDNA-seq data. DelSIEVE distinguishes deletions from mutations and artifacts, detecting more evolutionary events than previous methods. Simulations show high performance, and application to cancer samples reveals varying amounts of deletions and double mutants in different tumors.

bioinformatics↗

bioRxiv2022

Deep exponential families for single-cell data analysis

Single-cell gene expression data characterizes the complex heterogeneity of living systems. Tissues are composed of various cells with diverse cell states driven by different sets of genes. Cell states are often related in a hierarchical fashion, for example, in cell differentiation hierarchies. Clustering which respects a hierarchy, therefore, can improve functional interpretation and be leveraged to remove noise and batch effects when inferring gene signatures. For this task, we present single-cell Deep Exponential Families (scDEF), a multi-level Bayesian matrix factorization model for single-cell RNA-sequencing data. The model can identify hierarchies of cell states and be used for dimension reduction, gene signature identification, and batch integration. Additionally, it can be guided by known gene sets to jointly type cells and identify their hierarchical structure, or to find higher resolution states within the provided ones. In simulated and real data, scDEF outperforms alternative methods in finding cell populations across biologically distinct batches. We show that scDEF recovers cell type hierarchies in a whole adult animal, identifies a signature of response to interferon stimulation in peripheral blood mononuclear cells, and finds both patient-specific and shared cell states across nine high-grade serous ovarian cancer patients.

bioinformatics↗

bioRxiv2022

Single-cell phylogenies reveal deviations from clock-like, neutral evolution in cancer and healthy tissues

How tumors evolve affects cancer progression, therapy response, and relapse. However, whether tumor evolution is driven primarily by selectively advantageous or neutral mutations remains under debate. Resolving this controversy has so far been limited by the use of bulk sequencing data. Here, we leverage the high resolution of single-cell DNA sequencing (scDNA-seq) to test for clock-like, neutral evolution. Under neutrality, different cell lineages evolve at a similar rate, accumulating mutations according to a molecular clock. We developed and benchmarked a test of the somatic clock based on single-cell phylogenies and applied it to 22 scDNA-seq datasets. We rejected the clock in 10/13 cancer and 5/9 healthy datasets. The clock rejection in seven cancer datasets could be related to known driver mutations. Our findings demonstrate the power of scDNA-seq for studying somatic evolution and suggest that some cancer and healthy cell populations are driven by selection while others seem to evolve under neutrality.

evolutionary biology↗

bioRxiv2022

SIEVE: joint inference of single-nucleotide variants and cell phylogeny from single-cell DNA sequencing data

Single-cell DNA sequencing (scDNA-seq) has enabled the identification of single nucleotide somatic variants and the reconstruction of cell phylogenies. However, statistical phylogenetic models for cell phylogeny reconstruction from raw sequencing data are still in their infancy. Here we present SIEVE (SIngle-cell EVolution Explorer), a statistical method for the joint inference of somatic variants and cell phylogeny under the finite-sites assumption from scDNA-seq reads. SIEVE leverages raw read counts for all nucleotides at candidate variant sites, and corrects the acquisition bias of branch lengths. In our simulations, SIEVE outperforms other methods both in phylogenetic accuracy and variant calling accuracy. We apply SIEVE to three scDNA-seq datasets, for colorectal (CRC) and triple-negative breast cancer (TNBC), one of them generated by us. On simulated data, SIEVE reliably infers homo-and heterozygous somatic variants. The analysis of real data uncovers that double mutant genotypes are rare in CRC but unexpectedly frequent in TNBC samples.

bioinformatics↗

bioRxiv2022

Single-cell mutation calling and phylogenetic tree reconstruction with loss and recurrence

Tumours evolve as heterogeneous populations of cells, which may be distinguished by different genomic aberrations. The resulting intra-tumour heterogeneity plays an important role in cancer patient relapse and treatment failure, so that obtaining a clear understanding of each patients tumour composition and evolutionary history is key for personalised therapies. Single-cell sequencing now provides the possibility to resolve tumour heterogeneity at the highest resolution of individual tumour cells, but brings with it challenges related to the particular noise profiles of the sequencing protocols as well as the uncertainty of the underlying evolutionary process. By modelling the noise processes and allowing mutations to be lost or to reoccur during tumour evolution, we present a method to jointly call mutations in each cell, reconstruct the phylogenetic relationship between cells, and determine the locations of mutational losses and recurrences. Our Bayesian approach allows us to accurately call mutations as well as to quantify our certainty in such predictions. We show the advantages of allowing mutational loss or recurrence with simulated data and present its application to tumour single-cell sequencing data.

genomics↗

bioRxiv2022

Joint copy number and mutation phylogeny reconstruction fromsingle-cell amplicon sequencing data

Reconstructing the history of somatic DNA alterations can help understand the evolution of a tumor and predict its resistance to treatment. Single-cell DNA sequencing (scDNAseq) can be used to investigate clonal heterogeneity and to inform phylogeny reconstruction. However, most existing phylogenetic methods for scDNAseq data are designed either for single nucleotide variants (SNVs) or for large copy number alterations (CNAs), or are not applicable to targeted sequencing. Here, we develop COMPASS, a computational method for inferring the joint phylogeny of SNVs and CNAs from targeted scDNAseq data. We evaluate COMPASS on simulated data and apply it to several datasets including a cohort of 123 patients with acute myeloid leukemia. COMPASS detected clonal CNAs that could be orthogonally validated with bulk data, in addition to subclonal ones that require single-cell resolution, some of which point toward convergent evolution.

bioinformatics↗

bioRxiv2021

Discovering gene regulatory networks of multiple phenotypic groups using dynamic Bayesian networks

Dynamic Bayesian networks (DBNs) can be used for the discovery of gene regulatory networks from time series gene expression data. Here, we suggest a strategy for learning DBNs from gene expression data by employing a Bayesian approach that is scalable to large networks and is targeted at learning models with high predictive accuracy. Our framework can be used to learn DBNs for multiple groups of samples and highlight differences and similarities in their gene regulatory networks. We learn these DBN models based on different structural and parametric assumptions and select the optimal model based on the cross-validated predictive accuracy. We show in simulation studies that our approach is better equipped to prevent overfitting than techniques used in previous studies. We applied the proposed DBN-based classification approach to two time series transcriptomic datasets from the Gene Expression Omnibus database, each comprising data from distinct phenotypic groups of the same tissue type. In the first case, we used DBNs to characterize responders and non-responders to anti-cancer therapy. In the second case, we compared normal to tumor cells of colorectal tissue. The classification accuracy reached by the DBN-based classifier for both datasets was higher than reported previously. For the colorectal cancer dataset, our analysis suggested that GRNs for cancer and normal tissues have a lot of differences, which are most pronounced in the neighborhoods of oncogenes and known cancer tissue markers. The identified differences in gene networks of cancer and normal cells may be used for the discovery of targeted therapies.

systems biology↗

bioRxiv2021

Multi-omics subtyping of hepatocellular carcinoma patients using a Bayesian network mixture model

Comprehensive molecular characterization of cancer subtypes is essential for predicting clinical outcomes and searching for personalized treatments. We present bnClustOmics, a statistical model and computational tool for multi-omics unsupervised clustering, which serves a dual purpose: Clustering patient samples based on a Bayesian network mixture model and learning the networks of omics variables representing these clusters. The discovered networks encode interactions among all omics variables and provide a molecular characterization of each patient subgroup. We conducted simulation studies that demonstrated the advantages of our approach compared to other clustering methods in the case where the generative model is a mixture of Bayesian networks. We applied bnClustOmics to a hepatocellular carcinoma (HCC) dataset comprising genome (mutation and copy number), transcriptome, proteome, and phosphoproteome data. We identified three main HCC subtypes together with molecular characteristics, some of which are associated with survival even when adjusting for the clinical stage. Cluster-specific networks shed light on the links between genotypes and molecular phenotypes of samples within their respective clusters and suggest targets for personalized treatments. Author summaryMulti-omics approaches to cancer subtyping can provide more insights into molecular changes in tumors compared to single-omics approaches. However, most multi-omics clustering methods do not take into account that gene products interact, for example, as parts of protein complexes or signaling networks. Here we present bnClustOmics, a Bayesian network mixture model for unsupervised clustering of multi-omics data, which can represent dependencies among molecular changes of various omics types explicitly. Unlike other approaches that use data from public interaction databases as ground truth, bnClustOmics learns the dependencies between genes from the analyzed multi-omics dataset. At the same time, our approach can also account for prior knowledge from public interaction databases and use it to guide network learning without losing the ability to learn new dependencies. We applied bnClustOmics to a multi-omics HCC dataset and identified three subtypes similar to those identified in other HCC studies. The cluster-specific networks learned by bnClustOmics revealed additional insights into the molecular characterization of the discovered subgroups and highlighted the changes in signaling networks leading to distinct HCC phenotypes.

systems biology↗

bioRxiv2021

Mapping single-cell transcriptomes to copy number evolutionary trees

Cancer arises and evolves by the accumulation of somatic mutations that provide a selective advantage. The interplay of mutations and their functional consequences shape the evolutionary dynamics of tumors and contribute to different clinical outcomes. In the absence of scalable methods to jointly assay genomic and transcriptomic profiles of the same individual cell, the two data modalities are usually measured separately and need to be integrated computationally. Here, we introduce SCATrEx, a statistical model to map single-cell gene expression data onto the evolutionary history of copy number alterations of the tumor. SCATrEx jointly assigns cancer cells assayed with scRNA-seq to copy number profiles arranged in a copy number aberration tree and augments the tree with clone-specific clusters. Our simulations show that SCATrEx improves over both state-of-the-art unsupervised clustering methods and cell-to-clone assignment methods. In an application to real data, we observe that SCATrEx finds inter-clone and intra-clone gene expression heterogeneity not detectable using other integration methods. SCATrEx will allow for a better understanding of tumor evolution by jointly analysing the genomic and transcriptomic changes that drive it.

cancer biology↗

bioRxiv2021

Joint inference of repeated evolutionary trajectories and patterns of clonal exclusivity or co-occurrence from tumor mutation trees

Cancer progression is an evolutionary process shaped by both deterministic and stochastic forces. Multi-region and single-cell sequencing of tumors enable high-resolution reconstruction of the mutational history of each tumor and highlight the extensive diversity across tumors and patients. Resolving the interactions among mutations and recovering recurrent evolutionary processes may offer greater opportunities for successful therapeutic strategies. To this end, we present a novel probabilistic framework, called TreeMHN, for the joint inference of exclusivity patterns and recurrent trajectories from a cohort of intra-tumor phylogenetic trees. Through simulations, we show that TreeMHN outperforms existing alternatives that can only focus on one aspect of the task. By analyzing datasets of blood, lung, and breast cancers, we find the most likely evolutionary trajectories and mutational patterns, consistent with and enriching our current understanding of tumorigenesis. Moreover, TreeMHN facilitates the prediction of tumor evolution and provides probabilistic measures on the next mutational events given a tumor tree, a prerequisite for evolution-guided treatment strategies.

cancer biology↗

bioRxiv2021

The molecular chaperone DNAJB6 provides surveillance of FG-Nups and is required for interphase nuclear pore complex biogenesis

Biogenesis of nuclear pore complexes (NPCs) includes the formation of the permeability barrier composed of phenylalanine-glycine-rich nucleoporins (FG-Nups) that regulate the selective passage/crossing of biomolecules. The FG-Nups are intrinsically disordered and prone to liquid-liquid phase separate1,2 and aggregate when isolated3. It has remained largely unclear how FG-Nups are protected from making inappropriate interactions during NPC biogenesis. We found that DNAJB6, a molecular chaperone of the heat shock protein network, formed foci next to NPCs. The number of these foci decreases upon removal of proteins involved in the early steps of interphase NPC biogenesis. Reversely, when this process is stalled in the last steps, the number of DNAJB6-containing foci increases and they could be identified as herniations at the nuclear envelope (NE). Immunoelectron tomography showed that DNAJB6 localizes inside the lumen of the herniations arising at NPC biogenesis intermediates. Interestingly, loss of DNAJB6 results in annulate lamellae, which are structures containing partly assembled NPCs associated with disturbances in NPC biogenesis. We find that DNAJB6 binds to FG-Nups and can prevent the aggregation of the FG-region of several FG-Nups in cells and in vitro. Together, our data show that DNAJB6 provides quality control during NPC biogenesis and is the first molecular chaperone that is involved in the surveillance of native intrinsically disordered proteins, including FG-Nups.

molecular biology↗